Inspection Record

Groupe Marcelle Inc. — Health Canada Inspection Findings

Health CanadaInspected 2024-04-22 12 findingsDeviation, CAPA, and investigationValidation and qualificationLaboratory and QC controlsStability and storageMaterial and supplier controlOther quality systemRegulatory reporting and change controlEquipment and facilityComplaint and recall handlingComputer system validationCleaning validation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

2Validation and qualification

The qualification and/or verification of utilities and/or support systems was inadequate.

3Laboratory and QC controls

The validation and/or the documentation of test methods was inadequate.

4Stability and storage

The guidelines and/or procedures were inadequate in ensuring storage and/or transportation conditions would maintain the quality and safe distribution of the drug.

5Material and supplier control

Lots and/or batches of packaging materials were not examined and/or tested against the written specifications before they were used.

6Other quality system

The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

7Regulatory reporting and change control

The change control system was inadequate for ensuring changes are properly documented, evaluated, and/or approved.

8Equipment and facility

The equipment was not set-up, designed, operated, stored, and/or maintained to prevent potential contamination of drugs by other drugs and/or by foreign material. The design, location, and/or maintenance of the equipment was inadequate for allowing the equipment to serve its intended purpose

9Complaint and recall handling

The assessment, recording, follow-up, and/or investigation of complaints and/or other information about potentially defective products was inadequate.

10Equipment and facility

The availability, content and/or maintenance of the quality agreements between the supplier, fabricator, tester, packager, labeller, distributor, importer, and/or wholesaler was inadequate.

11Computer system validation

The creation, maintenance, processing, and/or review of laboratory data was inadequate. The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate. The electronic system was not validated for its intended use.

12Cleaning validation

The implementation, effectiveness, and/or validation of the cleaning procedures was inadequate for preventing unsanitary conditions. The implementation and/or the effectiveness of the sanitation program in preventing unsanitary conditions was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2024-04-22. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Groupe Marcelle Inc. findings history — including this company's other documents Health Canada documents, 2024 Go to Findings search